Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objectives of this early access program are to provide telaprevir for subjects with genotype 1 chronic hepatitis C with severe fibrosis and compensated cirrhosis who reside in countries in which telaprevir is not yet commercially available and who are not eligible for enrollment into an ongoing clinical study of telaprevir, and to collect additional safety and tolerability data on telaprevir treatment in combination with Peg-IFN-alfa and RBV.
Critère d'inclusion
- Chronic Hepatitis C Infection